Healthcare Sector Stocks
The Healthcare sector has a total of 1063 stocks, with a combined market cap of $8.17 trillion, total revenue of $4.59 trillion and a weighted average PE ratio of 40.69.
Market Cap
8.17T
Revenue
4.59T
Profits
200.69B
PE Ratio
40.69
Profit Margin
4.37%
Dividend Yield
0.44%
1063 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 881.12B | -1.67% | 2,015,971 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 551.06B | 0.97% | 10,141,611 | 96.36B |
| 3 | ABBV | AbbVie Inc. | 369.98B | -0.47% | 5,069,367 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 355.20B | -0.69% | 8,400,657 | 449.71B |
| 5 | AZN | AstraZeneca PLC | 284.82B | 1.29% | 1,225,224 | 60.44B |
| 6 | NVS | Novartis AG | 284.47B | 0.72% | 1,083,236 | 56.58B |
| 7 | MRK | Merck & Co., Inc. | 278.00B | 1.06% | 8,047,204 | 65.77B |
| 8 | NVO | Novo Nordisk A/S | 197.47B | -1.03% | 15,403,401 | 50.57B |
| 9 | AMGN | Amgen Inc. | 175.08B | -0.59% | 2,030,277 | 37.22B |
| 10 | TMO | Thermo Fisher Scientific Inc. | 164.26B | 0.83% | 1,908,611 | 45.20B |
| 11 | GILD | Gilead Sciences, Inc. | 160.99B | 0.07% | 5,182,250 | 29.74B |
| 12 | ISRG | Intuitive Surgical, Inc. | 155.80B | 4.46% | 2,119,623 | 10.58B |
| 13 | ABT | Abbott Laboratories | 153.12B | 4.07% | 12,346,980 | 45.13B |
| 14 | PFE | Pfizer Inc. | 144.37B | - | 34,111,286 | 63.32B |
| 15 | CVS | CVS Health Corporation | 122.48B | 0.10% | 7,208,687 | 405.62B |
| 16 | SYK | Stryker Corporation | 120.08B | 2.11% | 3,515,453 | 25.27B |
| 17 | BMY | Bristol-Myers Squibb Company | 117.03B | 0.54% | 11,659,255 | 48.48B |
| 18 | DHR | Danaher Corporation | 115.98B | 1.20% | 4,955,207 | 24.78B |
| 19 | VRTX | Vertex Pharmaceuticals Incorporated | 110.81B | -0.08% | 1,451,055 | 12.22B |
| 20 | SNY | Sanofi | 103.85B | 1.99% | 2,427,980 | 54.60B |
| 21 | GSK | GSK plc | 100.34B | 1.19% | 3,108,116 | 43.29B |
| 22 | MDT | Medtronic plc | 99.27B | 1.54% | 10,973,289 | 35.48B |
| 23 | HCA | HCA Healthcare, Inc. | 93.79B | -0.05% | 1,423,618 | 76.39B |
| 24 | MCK | McKesson Corporation | 93.27B | 2.02% | 1,199,553 | 403.43B |
| 25 | ELV | Elevance Health, Inc. | 85.58B | 0.35% | 1,508,426 | 200.42B |
| 26 | BSX | Boston Scientific Corporation | 83.12B | 6.15% | 16,769,063 | 20.61B |
| 27 | CI | The Cigna Group | 75.84B | 0.50% | 1,375,063 | 277.89B |
| 28 | REGN | Regeneron Pharmaceuticals, Inc. | 64.06B | -9.82% | 2,996,891 | 14.92B |
| 29 | TAK | Takeda Pharmaceutical Company Limited | 52.20B | -0.24% | 4,030,943 | 28.34B |
| 30 | COR | Cencora, Inc. | 50.95B | 1.61% | 1,975,754 | 328.68B |
| 31 | ARGX | argenx SE | 48.90B | -2.88% | 306,687 | 4.74B |
| 32 | EW | Edwards Lifesciences Corporation | 47.44B | 1.24% | 4,180,416 | 6.30B |
| 33 | MDLN | Medline Inc. | 47.32B | -0.47% | 7,662,868 | 29.14B |
| 34 | CAH | Cardinal Health, Inc. | 46.79B | 2.34% | 2,413,953 | 250.74B |
| 35 | IDXX | IDEXX Laboratories, Inc. | 43.05B | 3.21% | 644,929 | 4.45B |
| 36 | HLN | Haleon plc | 40.00B | 2.34% | 9,041,010 | 14.85B |
| 37 | TEVA | Teva Pharmaceutical Industries Limited | 39.63B | -0.76% | 4,976,942 | 17.35B |
| 38 | BDX | Becton, Dickinson and Company | 39.22B | -0.78% | 3,814,083 | 22.23B |
| 39 | ALNY | Alnylam Pharmaceuticals, Inc. | 38.22B | -0.25% | 873,362 | 4.29B |
| 40 | HUM | Humana Inc. | 36.74B | 0.29% | 1,744,691 | 137.20B |
| 41 | WAT | Waters Corporation | 32.62B | 0.90% | 833,657 | 3.77B |
| 42 | ONC | BeOne Medicines AG | 32.58B | -0.06% | 217,638 | 5.70B |
| 43 | ZTS | Zoetis Inc. | 32.58B | 4.72% | 8,848,290 | 9.53B |
| 44 | ALC | Alcon Inc. | 31.90B | 3.66% | 2,673,929 | 10.63B |
| 45 | A | Agilent Technologies, Inc. | 31.68B | 0.37% | 1,684,901 | 7.07B |
| 46 | RVMD | Revolution Medicines, Inc. | 30.69B | -0.89% | 2,345,020 | - |
| 47 | RPRX | Royalty Pharma plc | 29.98B | -1.48% | 3,411,899 | 2.44B |
| 48 | RMD | ResMed Inc. | 29.61B | 1.12% | 1,033,744 | 5.54B |
| 49 | IQV | IQVIA Holdings Inc. | 28.84B | 2.18% | 1,200,352 | 16.63B |
| 50 | CNC | Centene Corporation | 28.75B | -0.07% | 4,428,984 | 178.33B |
| 51 | BIIB | Biogen Inc. | 28.33B | -0.54% | 1,051,357 | 9.94B |
| 52 | GEHC | GE HealthCare Technologies Inc. | 27.98B | 1.23% | 4,998,376 | 20.98B |
| 53 | NTRA | Natera, Inc. | 27.57B | 3.32% | 2,145,438 | 2.50B |
| 54 | VEEV | Veeva Systems Inc. | 26.74B | 3.14% | 2,450,963 | 3.20B |
| 55 | DXCM | DexCom, Inc. | 25.12B | 5.61% | 13,510,886 | 4.82B |
| 56 | PHG | Koninklijke Philips N.V. | 24.81B | 3.25% | 1,218,070 | 20.34B |
| 57 | UTHR | United Therapeutics Corporation | 24.07B | -0.28% | 309,659 | 3.17B |
| 58 | INSM | Insmed Incorporated | 23.23B | -1.82% | 3,834,611 | 819.56M |
| 59 | BNTX | BioNTech SE | 22.47B | -0.78% | 989,337 | 3.23B |
| 60 | MTD | Mettler-Toledo International Inc. | 21.72B | 4.19% | 261,537 | 4.09B |
| 61 | WST | West Pharmaceutical Services, Inc. | 21.51B | 0.50% | 515,365 | 3.22B |
| 62 | ILMN | Illumina, Inc. | 21.41B | -0.72% | 1,440,928 | 4.39B |
| 63 | DGX | Quest Diagnostics Incorporated | 21.01B | 1.73% | 926,153 | 11.28B |
| 64 | LH | Labcorp Holdings Inc. | 20.96B | 2.06% | 465,997 | 14.14B |
| 65 | STE | STERIS plc | 20.88B | 0.36% | 833,728 | 5.94B |
| 66 | ROIV | Roivant Sciences Ltd. | 20.43B | -2.53% | 14,718,759 | 13.31M |
| 67 | VTRS | Viatris Inc. | 19.22B | 0.12% | 10,008,916 | 14.56B |
| 68 | MRNA | Moderna, Inc. | 19.09B | -1.90% | 5,028,715 | 2.23B |
| 69 | INCY | Incyte Corporation | 19.02B | -0.13% | 1,020,911 | 5.36B |
| 70 | THC | Tenet Healthcare Corporation | 16.58B | -2.14% | 1,102,437 | 21.46B |
| 71 | ZBH | Zimmer Biomet Holdings, Inc. | 16.47B | 1.72% | 2,303,230 | 8.41B |
| 72 | GMAB | Genmab A/S | 16.17B | -0.64% | 2,858,105 | 3.90B |
| 73 | NBIX | Neurocrine Biosciences, Inc. | 15.81B | -0.76% | 1,127,634 | 3.10B |
| 74 | ASND | Ascendis Pharma A/S | 14.76B | -1.19% | 583,990 | 998.25M |
| 75 | JAZZ | Jazz Pharmaceuticals plc | 14.40B | 0.34% | 685,870 | 4.44B |
| 76 | RGC | Regencell Bioscience Holdings Limited | 13.74B | -2.76% | 55,166 | - |
| 77 | SOLV | Solventum Corporation | 13.18B | 2.52% | 1,519,682 | 8.26B |
| 78 | PEN | Penumbra, Inc. | 12.84B | 1.31% | 435,352 | 1.45B |
| 79 | SNN | Smith & Nephew plc | 12.84B | 2.57% | 1,034,240 | 6.16B |
| 80 | DVA | DaVita Inc. | 12.81B | -0.11% | 893,107 | 13.84B |
| 81 | BBIO | BridgeBio Pharma, Inc. | 12.79B | -1.22% | 3,415,449 | 579.96M |
| 82 | GH | Guardant Health, Inc. | 12.68B | 0.78% | 1,218,307 | 1.08B |
| 83 | EXEL | Exelixis, Inc. | 12.53B | -0.58% | 2,596,104 | 2.38B |
| 84 | SMMT | Summit Therapeutics Inc. | 12.43B | -5.04% | 4,421,302 | - |
| 85 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.04B | -0.28% | 325,810 | 1.13B |
| 86 | MEDP | Medpace Holdings, Inc. | 12.01B | 1.30% | 301,167 | 2.68B |
| 87 | IONS | Ionis Pharmaceuticals, Inc. | 11.98B | -2.30% | 2,211,491 | 1.06B |
| 88 | FMS | Fresenius Medical Care AG | 11.92B | 2.87% | 736,723 | 22.32B |
| 89 | COO | The Cooper Companies, Inc. | 11.89B | 2.23% | 2,728,782 | 4.15B |
| 90 | AXSM | Axsome Therapeutics, Inc. | 11.70B | -0.14% | 464,521 | 708.24M |
| 91 | BTSG | BrightSpring Health Services, Inc. | 11.55B | -2.97% | 2,034,083 | 13.65B |
| 92 | RDY | Dr. Reddy's Laboratories Limited | 11.51B | -0.07% | 2,287,182 | 3.58B |
| 93 | ALGN | Align Technology, Inc. | 11.37B | 0.97% | 982,750 | 4.10B |
| 94 | GMED | Globus Medical, Inc. | 10.71B | 2.99% | 1,760,734 | 3.10B |
| 95 | RVTY | Revvity, Inc. | 10.65B | 1.61% | 1,050,988 | 2.90B |
| 96 | PODD | Insulet Corporation | 10.56B | 3.41% | 1,563,690 | 2.90B |
| 97 | EHC | Encompass Health Corporation | 10.53B | -0.51% | 1,133,215 | 6.07B |
| 98 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.42B | -3.55% | 1,523,702 | 622.01M |
| 99 | UHS | Universal Health Services, Inc. | 10.25B | 0.37% | 624,920 | 17.76B |
| 100 | ENSG | The Ensign Group, Inc. | 10.24B | -0.57% | 424,212 | 5.27B |
| 101 | CYTK | Cytokinetics, Incorporated | 10.21B | -0.88% | 1,798,156 | 105.82M |
| 102 | ELAN | Elanco Animal Health Incorporated | 9.95B | 0.35% | 7,877,363 | 4.89B |
| 103 | MOH | Molina Healthcare, Inc. | 9.63B | -0.06% | 963,135 | 43.10B |
| 104 | BMRN | BioMarin Pharmaceutical Inc. | 9.60B | -4.13% | 3,485,981 | 3.24B |
| 105 | MASI | Masimo Corporation | 9.36B | 0.18% | 1,578,414 | 1.56B |
| 106 | BAX | Baxter International Inc. | 9.19B | 2.83% | 6,252,107 | 11.32B |
| 107 | PRAX | Praxis Precision Medicines, Inc. | 8.94B | -6.44% | 330,012 | 7.46M |
| 108 | ABVX | ABIVAX Société Anonyme | 8.87B | -0.86% | 798,158 | 5.37M |
| 109 | ICLR | ICON Public Limited Company | 8.69B | -2.23% | 567,475 | 8.10B |
| 110 | KRYS | Krystal Biotech, Inc. | 8.60B | -4.75% | 299,221 | 417.30M |
| 111 | IBRX | ImmunityBio, Inc. | 8.38B | 0.38% | 13,084,842 | 140.98M |
| 112 | GKOS | Glaukos Corporation | 8.35B | -1.27% | 814,311 | 551.35M |
| 113 | HSIC | Henry Schein, Inc. | 8.28B | -0.04% | 1,347,905 | 13.38B |
| 114 | HALO | Halozyme Therapeutics, Inc. | 8.00B | 0.48% | 1,780,901 | 1.51B |
| 115 | NUVL | Nuvalent, Inc. | 7.89B | -2.35% | 440,686 | - |
| 116 | TEM | Tempus AI, Inc. | 7.83B | -0.71% | 5,967,959 | 1.36B |
| 117 | OSCR | Oscar Health, Inc. | 7.62B | 8.49% | 13,779,511 | 13.30B |
| 118 | BIO | Bio-Rad Laboratories, Inc. | 7.54B | 13.85% | 1,263,767 | 2.59B |
| 119 | ATR | AptarGroup, Inc. | 7.39B | 0.99% | 433,079 | 3.87B |
| 120 | CRL | Charles River Laboratories International, Inc. | 7.22B | -0.61% | 1,628,570 | 4.03B |
| 121 | HQY | HealthEquity, Inc. | 7.02B | 1.06% | 940,748 | 1.31B |
| 122 | PCVX | Vaxcyte, Inc. | 6.99B | -7.54% | 1,715,055 | - |
| 123 | QGEN | Qiagen N.V. | 6.99B | 2.43% | 2,996,993 | 2.10B |
| 124 | TECH | Bio-Techne Corporation | 6.96B | 2.61% | 4,102,027 | 1.21B |
| 125 | GRFS | Grifols, S.A. | 6.56B | 2.74% | 535,768 | 8.58B |
| 126 | KYMR | Kymera Therapeutics, Inc. | 6.55B | -3.09% | 681,073 | 51.48M |
| 127 | BRKR | Bruker Corporation | 6.51B | -0.30% | 2,085,975 | 3.46B |
| 128 | PTGX | Protagonist Therapeutics, Inc. | 6.48B | -1.41% | 447,230 | 74.06M |
| 129 | CELC | Celcuity Inc. | 6.39B | -3.99% | 721,383 | - |
| 130 | ALKS | Alkermes plc | 6.20B | -0.77% | 1,571,921 | 1.56B |
| 131 | CNTA | Centessa Pharmaceuticals plc | 6.13B | 0.13% | 911,936 | 15.00M |
| 132 | SYRE | Spyre Therapeutics, Inc. | 6.09B | -6.46% | 1,079,527 | - |
| 133 | LNTH | Lantheus Holdings, Inc. | 6.06B | -0.83% | 1,358,130 | 1.55B |
| 134 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.95B | -4.07% | 694,680 | 217.17M |
| 135 | CORT | Corcept Therapeutics Incorporated | 5.92B | -2.22% | 816,451 | 769.10M |
| 136 | APGE | Apogee Therapeutics, Inc. | 5.90B | -2.95% | 748,131 | - |
| 137 | RGEN | Repligen Corporation | 5.88B | 1.29% | 1,568,446 | 763.34M |
| 138 | CHE | Chemed Corporation | 5.84B | 1.63% | 234,520 | 2.54B |
| 139 | PACS | PACS Group, Inc. | 5.83B | -1.79% | 898,662 | 5.43B |
| 140 | MIRM | Mirum Pharmaceuticals, Inc. | 5.82B | -6.56% | 1,011,762 | 569.61M |
| 141 | PTCT | PTC Therapeutics, Inc. | 5.82B | -1.85% | 833,987 | 827.11M |
| 142 | TFX | Teleflex Incorporated | 5.77B | 0.54% | 796,848 | 2.13B |
| 143 | BLCO | Bausch + Lomb Corporation | 5.74B | 0.12% | 454,588 | 5.21B |
| 144 | SRRK | Scholar Rock Holding Corporation | 5.68B | -3.99% | 909,821 | - |
| 145 | BLTE | Belite Bio, Inc | 5.62B | -0.07% | 121,231 | - |
| 146 | TGTX | TG Therapeutics, Inc. | 5.60B | -0.05% | 1,602,646 | 700.35M |
| 147 | CGON | CG Oncology, Inc. | 5.55B | -5.98% | 1,378,288 | 5.07M |
| 148 | IMVT | Immunovant, Inc. | 5.40B | -3.49% | 1,275,269 | - |
| 149 | COGT | Cogent Biosciences, Inc. | 5.36B | -4.04% | 1,669,188 | - |
| 150 | XENE | Xenon Pharmaceuticals Inc. | 5.19B | -1.25% | 676,957 | 7.50M |
| 151 | AVTR | Avantor, Inc. | 5.19B | -0.26% | 8,911,140 | 6.55B |
| 152 | HIMS | Hims & Hers Health, Inc. | 5.16B | -11.02% | 32,292,392 | 2.37B |
| 153 | LQDA | Liquidia Corporation | 5.07B | 0.07% | 1,412,116 | 288.07M |
| 154 | LEGN | Legend Biotech Corporation | 5.01B | -2.07% | 1,790,984 | 1.14B |
| 155 | STVN | Stevanato Group S.p.A. | 4.86B | -1.11% | 324,820 | 1.39B |
| 156 | CRSP | CRISPR Therapeutics AG | 4.68B | 0.31% | 1,779,094 | 4.10M |
| 157 | DNTH | Dianthus Therapeutics, Inc. | 4.57B | -2.97% | 601,081 | 1.34M |
| 158 | SHC | Sotera Health Company | 4.38B | 0.52% | 3,918,912 | 1.19B |
| 159 | CAI | Caris Life Sciences, Inc. | 4.27B | 3.78% | 5,441,242 | 907.29M |
| 160 | RDNT | RadNet, Inc. | 4.26B | 3.40% | 467,035 | 2.14B |
| 161 | HNGE | Hinge Health, Inc. | 4.23B | 0.39% | 1,069,752 | 646.34M |
| 162 | LGND | Ligand Pharmaceuticals Incorporated | 4.17B | -2.50% | 143,659 | 274.48M |
| 163 | MANE | Veradermics, Incorporated | 4.13B | 0.66% | 451,200 | - |
| 164 | KNSA | Kiniksa Pharmaceuticals International, plc | 4.13B | -5.08% | 559,923 | 754.05M |
| 165 | TVTX | Travere Therapeutics, Inc. | 3.99B | 0.70% | 1,774,766 | 536.20M |
| 166 | LIVN | LivaNova PLC | 3.97B | 3.19% | 547,973 | 1.43B |
| 167 | BLLN | BillionToOne, Inc. | 3.96B | 4.22% | 600,506 | 354.54M |
| 168 | NAMS | NewAmsterdam Pharma Company N.V. | 3.93B | -3.67% | 1,960,060 | 22.57M |
| 169 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.82B | 0.16% | 4,171,703 | 596.96M |
| 170 | AMRX | Amneal Pharmaceuticals, Inc. | 3.80B | -0.08% | 1,316,194 | 3.05B |
| 171 | MMSI | Merit Medical Systems, Inc. | 3.80B | 3.72% | 919,429 | 1.54B |
| 172 | NVST | Envista Holdings Corporation | 3.77B | -0.30% | 5,799,382 | 2.81B |
| 173 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.66B | -5.63% | 822,686 | 18.07M |
| 174 | IRTC | iRhythm Holdings, Inc. | 3.65B | -2.68% | 813,197 | 787.85M |
| 175 | DOCS | Doximity, Inc. | 3.62B | 3.22% | 7,423,104 | 644.86M |
| 176 | WAY | Waystar Holding Corp. | 3.56B | 3.46% | 2,477,423 | 1.16B |
| 177 | ACAD | ACADIA Pharmaceuticals Inc. | 3.54B | -3.32% | 1,623,325 | 1.10B |
| 178 | OGN | Organon & Co. | 3.52B | 0.15% | 4,234,308 | 6.16B |
| 179 | ORKA | Oruka Therapeutics, Inc. | 3.52B | -5.80% | 1,906,041 | - |
| 180 | WRBY | Warby Parker Inc. | 3.52B | -0.28% | 2,786,391 | 890.57M |
| 181 | TLX | Telix Pharmaceuticals Limited | 3.46B | -2.65% | 86,783 | 803.79M |
| 182 | EWTX | Edgewise Therapeutics, Inc. | 3.41B | -4.14% | 955,531 | - |
| 183 | ALHC | Alignment Healthcare, Inc. | 3.37B | 3.50% | 3,612,112 | 4.26B |
| 184 | CON | Concentra Group Holdings Parent, Inc. | 3.34B | 0.81% | 530,350 | 2.23B |
| 185 | VKTX | Viking Therapeutics, Inc. | 3.33B | -5.22% | 3,346,447 | - |
| 186 | VCYT | Veracyte, Inc. | 3.31B | 7.85% | 1,489,598 | 541.74M |
| 187 | ERAS | Erasca, Inc. | 3.19B | 0.39% | 3,016,716 | - |
| 188 | BKD | Brookdale Senior Living Inc. | 3.17B | 1.84% | 3,996,020 | 3.00B |
| 189 | TWST | Twist Bioscience Corporation | 3.10B | 1.26% | 1,144,948 | 409.48M |
| 190 | OPCH | Option Care Health, Inc. | 3.09B | 0.87% | 2,855,588 | 5.67B |
| 191 | ICUI | ICU Medical, Inc. | 3.08B | 3.67% | 351,141 | 2.16B |
| 192 | NHC | National HealthCare Corporation | 3.07B | 1.37% | 90,361 | 1.53B |
| 193 | MMED | MiniMed Group, Inc. | 3.06B | 0.74% | 631,565 | 2.99B |
| 194 | ITGR | Integer Holdings Corporation | 3.05B | 2.05% | 359,425 | 1.86B |
| 195 | LFST | LifeStance Health Group, Inc. | 3.03B | 1.96% | 3,603,889 | 1.49B |
| 196 | PRVA | Privia Health Group, Inc. | 2.99B | 3.22% | 611,707 | 2.25B |
| 197 | TNGX | Tango Therapeutics, Inc. | 2.98B | 0.34% | 3,258,566 | 56.99M |
| 198 | GMRS | GMR Solutions Inc. | 2.98B | - | 742,812 | 5.74B |
| 199 | RCUS | Arcus Biosciences, Inc. | 2.94B | -1.60% | 1,126,956 | 236.00M |
| 200 | DNLI | Denali Therapeutics Inc. | 2.92B | -1.18% | 1,709,434 | - |
| 201 | SUPN | Supernus Pharmaceuticals, Inc. | 2.81B | -2.23% | 568,938 | 776.83M |
| 202 | SLNO | Soleno Therapeutics, Inc. | 2.76B | 0.04% | - | 285.01M |
| 203 | DYN | Dyne Therapeutics, Inc. | 2.73B | -4.34% | 1,584,989 | - |
| 204 | TXG | 10x Genomics, Inc. | 2.72B | 1.18% | 2,653,248 | 638.78M |
| 205 | TARS | Tarsus Pharmaceuticals, Inc. | 2.70B | 0.54% | 546,930 | 535.08M |
| 206 | ALMS | Alumis Inc. | 2.70B | -7.52% | 1,281,353 | 8.40M |
| 207 | BEAM | Beam Therapeutics Inc. | 2.67B | -4.01% | 2,002,872 | 164.01M |
| 208 | HAE | Haemonetics Corporation | 2.66B | 1.76% | 614,289 | 1.33B |
| 209 | GRAL | GRAIL, Inc. | 2.61B | 1.78% | 421,224 | 156.12M |
| 210 | GPCR | Structure Therapeutics Inc. | 2.57B | -6.67% | 755,975 | - |
| 211 | IRON | Disc Medicine, Inc. | 2.55B | -0.01% | 582,176 | - |
| 212 | KLRA | Kailera Therapeutics, Inc. | 2.53B | -7.08% | 602,097 | - |
| 213 | ARQT | Arcutis Biotherapeutics, Inc. | 2.51B | -6.05% | 1,412,122 | 415.62M |
| 214 | IDYA | IDEAYA Biosciences, Inc. | 2.49B | 0.39% | 907,105 | 225.27M |
| 215 | VERA | Vera Therapeutics, Inc. | 2.47B | -7.96% | 1,597,308 | - |
| 216 | ELVN | Enliven Therapeutics, Inc. | 2.41B | -4.14% | 510,761 | - |
| 217 | NBTX | Nanobiotix S.A. | 2.41B | -3.92% | 38,230 | 38.27M |
| 218 | RARE | Ultragenyx Pharmaceutical Inc. | 2.38B | -3.24% | 1,548,682 | 670.00M |
| 219 | CLDX | Celldex Therapeutics, Inc. | 2.37B | -3.57% | 826,076 | 865.00K |
| 220 | TMDX | TransMedics Group, Inc. | 2.36B | 8.13% | 1,943,214 | 635.89M |
| 221 | ACHC | Acadia Healthcare Company, Inc. | 2.33B | -1.94% | 1,909,700 | 3.37B |
| 222 | RLAY | Relay Therapeutics, Inc. | 2.32B | -0.82% | 2,297,391 | 10.68M |
| 223 | NKTR | Nektar Therapeutics | 2.31B | -3.10% | 1,234,631 | 55.63M |
| 224 | LMAT | LeMaitre Vascular, Inc. | 2.30B | 3.62% | 481,305 | 256.28M |
| 225 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.28B | -0.55% | 3,797,371 | 885.72M |
| 226 | GRDN | Guardian Pharmacy Services, Inc. | 2.27B | -2.16% | 272,798 | 1.46B |
| 227 | IMNM | Immunome, Inc. | 2.25B | -4.69% | 1,327,414 | 4.02M |
| 228 | DFTX | Definium Therapeutics, Inc. | 2.23B | -2.43% | 1,343,451 | - |
| 229 | AXGN | Axogen, Inc. | 2.23B | 2.34% | 898,067 | 238.11M |
| 230 | HTFL | HeartFlow, Inc. | 2.21B | -9.45% | 1,277,218 | 191.42M |
| 231 | PBH | Prestige Consumer Healthcare Inc. | 2.21B | -0.32% | 862,437 | 1.09B |
| 232 | KOD | Kodiak Sciences Inc. | 2.19B | -5.40% | 708,915 | - |
| 233 | MLYS | Mineralys Therapeutics, Inc. | 2.18B | -3.62% | 967,657 | - |
| 234 | TYRA | Tyra Biosciences, Inc. | 2.12B | -3.73% | 757,299 | - |
| 235 | ZLAB | Zai Lab Limited | 2.12B | -8.40% | 1,649,196 | 453.28M |
| 236 | HCM | HUTCHMED (China) Limited | 2.10B | -4.48% | 62,383 | 548.51M |
| 237 | SEM | Select Medical Holdings Corporation | 2.04B | -0.12% | 1,003,203 | 5.52B |
| 238 | ADPT | Adaptive Biotechnologies Corporation | 2.03B | -0.94% | 1,593,298 | 295.41M |
| 239 | NVCR | NovoCure Limited | 2.02B | -0.68% | 1,822,159 | 674.41M |
| 240 | AUPH | Aurinia Pharmaceuticals Inc. | 2.01B | 2.09% | 1,205,538 | 298.30M |
| 241 | BHC | Bausch Health Companies Inc. | 1.99B | -1.48% | 781,621 | 10.53B |
| 242 | XRAY | DENTSPLY SIRONA Inc. | 1.97B | -2.48% | 5,480,356 | 3.68B |
| 243 | OMCL | Omnicell, Inc. | 1.97B | 0.23% | 436,443 | 1.23B |
| 244 | ADMA | ADMA Biologics, Inc. | 1.94B | 1.33% | 3,351,887 | 509.86M |
| 245 | ASTH | Astrana Health, Inc. | 1.93B | 1.88% | 491,742 | 3.53B |
| 246 | ESTA | Establishment Labs Holdings Inc. | 1.93B | -0.20% | 436,526 | 229.58M |
| 247 | TRVI | Trevi Therapeutics, Inc. | 1.91B | -5.42% | 1,410,169 | - |
| 248 | MESO | Mesoblast Limited | 1.89B | -2.33% | 163,880 | 65.38M |
| 249 | PHVS | Pharvaris N.V. | 1.88B | -5.23% | 347,438 | - |
| 250 | PGNY | Progyny, Inc. | 1.88B | 3.44% | 1,850,930 | 1.29B |
| 251 | NEOG | Neogen Corporation | 1.86B | 4.52% | 2,840,927 | 870.56M |
| 252 | OCUL | Ocular Therapeutix, Inc. | 1.83B | -8.52% | 2,984,672 | 52.04M |
| 253 | MD | Pediatrix Medical Group, Inc. | 1.82B | 0.67% | 708,778 | 1.93B |
| 254 | STOK | Stoke Therapeutics, Inc. | 1.81B | -3.49% | 745,369 | 32.08M |
| 255 | SGRY | Surgery Partners, Inc. | 1.80B | -0.22% | 1,636,880 | 3.34B |
| 256 | SRPT | Sarepta Therapeutics, Inc. | 1.80B | -3.08% | 3,902,855 | 2.18B |
| 257 | CLOV | Clover Health Investments, Corp. | 1.79B | -2.31% | 8,080,215 | 2.21B |
| 258 | ZYME | Zymeworks Inc. | 1.78B | 2.09% | 750,241 | 81.26M |
| 259 | VCEL | Vericel Corporation | 1.78B | 5.57% | 524,335 | 292.09M |
| 260 | VRDN | Viridian Therapeutics, Inc. | 1.78B | -4.28% | 2,361,894 | 70.92M |
| 261 | NTLA | Intellia Therapeutics, Inc. | 1.77B | -7.17% | 9,646,283 | 66.09M |
| 262 | PLSE | Pulse Biosciences, Inc. | 1.77B | 4.32% | 437,147 | 751.00K |
| 263 | SION | Sionna Therapeutics, Inc. | 1.77B | -2.44% | 341,616 | - |
| 264 | AAPG | Ascentage Pharma Group International | 1.77B | -4.82% | 9,271 | 82.08M |
| 265 | LKFT | Lakefront Biotherapeutics NV | 1.76B | -1.33% | 212,558 | 1.20B |
| 266 | HRMY | Harmony Biosciences Holdings, Inc. | 1.73B | -0.86% | 671,961 | 899.11M |
| 267 | SNDA | Sonida Senior Living, Inc. | 1.72B | -2.22% | 547,822 | 367.34M |
| 268 | SNDX | Syndax Pharmaceuticals, Inc. | 1.72B | -4.05% | 1,357,083 | 217.17M |
| 269 | ANAB | AnaptysBio, Inc. | 1.71B | -6.98% | 535,580 | 232.39M |
| 270 | ADUS | Addus HomeCare Corporation | 1.69B | 1.82% | 244,223 | 1.45B |
| 271 | RAPP | Rapport Therapeutics, Inc. | 1.68B | -5.10% | 275,474 | 20.00M |
| 272 | ANIP | ANI Pharmaceuticals, Inc. | 1.68B | 1.70% | 169,201 | 923.71M |
| 273 | UFPT | UFP Technologies, Inc. | 1.68B | 1.53% | 176,576 | 608.85M |
| 274 | AGIO | Agios Pharmaceuticals, Inc. | 1.68B | 0.14% | 757,914 | 66.05M |
| 275 | AVAH | Aveanna Healthcare Holdings Inc. | 1.68B | -0.26% | 2,589,764 | 2.52B |
| 276 | OCS | Oculis Holding AG | 1.66B | -7.33% | 395,605 | 1.40M |
| 277 | GENB | Generate Biomedicines, Inc. | 1.66B | -18.72% | 1,811,077 | 30.30M |
| 278 | CAPR | Capricor Therapeutics, Inc. | 1.62B | -2.69% | 917,276 | 11.13M |
| 279 | INVA | Innoviva, Inc. | 1.61B | -0.77% | 985,951 | 420.69M |
| 280 | STAA | STAAR Surgical Company | 1.61B | 0.75% | 1,071,810 | 290.38M |
| 281 | NRIX | Nurix Therapeutics, Inc. | 1.60B | -2.21% | 2,195,128 | 71.78M |
| 282 | QURE | uniQure N.V. | 1.57B | -7.84% | 1,815,114 | 18.09M |
| 283 | TSHA | Taysha Gene Therapies, Inc. | 1.56B | -8.64% | 2,293,276 | 7.47M |
| 284 | INBX | Inhibrx Biosciences, Inc. | 1.55B | -2.61% | 393,775 | 1.30M |
| 285 | RXRX | Recursion Pharmaceuticals, Inc. | 1.53B | -1.37% | 19,169,491 | 66.41M |
| 286 | ATAI | AtaiBeckley Inc. | 1.52B | 3.36% | 7,869,632 | 3.49M |
| 287 | GLUE | Monte Rosa Therapeutics, Inc. | 1.52B | -0.77% | 642,139 | 42.95M |
| 288 | IOVA | Iovance Biotherapeutics, Inc. | 1.51B | -1.74% | 10,237,083 | 285.61M |
| 289 | ARDX | Ardelyx, Inc. | 1.51B | -1.93% | 3,132,971 | 427.68M |
| 290 | PVLA | Palvella Therapeutics, Inc. | 1.51B | -8.04% | 305,400 | - |
| 291 | DMRA | Damora Therapeutics, Inc. | 1.50B | 1.22% | 522,951 | - |
| 292 | GHRS | GH Research PLC | 1.49B | 1.36% | 373,875 | - |
| 293 | AHG | Akso Health Group | 1.48B | - | 18,309 | 14.84M |
| 294 | PRCT | PROCEPT BioRobotics Corporation | 1.48B | -0.42% | 1,648,877 | 322.02M |
| 295 | VIR | Vir Biotechnology, Inc. | 1.48B | -0.23% | 1,515,947 | 65.50M |
| 296 | HCSG | Healthcare Services Group, Inc. | 1.48B | 1.36% | 459,942 | 1.85B |
| 297 | PRGO | Perrigo Company plc | 1.48B | 0.66% | 2,276,105 | 4.18B |
| 298 | MBX | MBX Biosciences, Inc. | 1.47B | -4.53% | 917,487 | - |
| 299 | NVAX | Novavax, Inc. | 1.47B | -1.43% | 4,837,341 | 596.34M |
| 300 | NUVB | Nuvation Bio Inc. | 1.47B | -2.55% | 4,623,226 | 143.05M |
| 301 | ARDT | Ardent Health, Inc. | 1.45B | 0.40% | 368,593 | 6.43B |
| 302 | ENOV | Enovis Corporation | 1.45B | 3.95% | 1,269,356 | 2.28B |
| 303 | PGEN | Precigen, Inc. | 1.45B | -7.92% | 5,177,867 | 31.60M |
| 304 | AGL | agilon health, inc. | 1.45B | 6.20% | 399,547 | 5.82B |
| 305 | ALMR | Alamar Biosciences, Inc. | 1.45B | -3.16% | 272,538 | 87.16M |
| 306 | IMCR | Immunocore Holdings plc | 1.44B | 1.14% | 237,988 | 412.81M |
| 307 | ATRC | AtriCure, Inc. | 1.44B | 1.28% | 732,783 | 552.16M |
| 308 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.43B | -3.24% | 940,680 | -665.00K |
| 309 | AHCO | AdaptHealth Corp. | 1.43B | 0.56% | 1,342,146 | 3.29B |
| 310 | CMPS | COMPASS Pathways plc | 1.42B | 1.83% | 7,041,092 | - |
| 311 | KALV | KalVista Pharmaceuticals, Inc. | 1.42B | 0.11% | 2,048,832 | 114.48M |
| 312 | IMTX | Immatics N.V. | 1.42B | -2.30% | 680,275 | 43.00M |
| 313 | URGN | UroGen Pharma Ltd. | 1.39B | -0.69% | 830,772 | 140.49M |
| 314 | PAHC | Phibro Animal Health Corporation | 1.39B | -0.55% | 410,541 | 1.50B |
| 315 | SLS | SELLAS Life Sciences Group, Inc. | 1.36B | 2.97% | 8,924,260 | - |
| 316 | MAZE | Maze Therapeutics, Inc. | 1.36B | -4.15% | 596,266 | 20.00M |
| 317 | FTRE | Fortrea Holdings Inc. | 1.29B | -0.51% | 998,143 | 2.71B |
| 318 | BHVN | Biohaven Ltd. | 1.28B | -3.08% | 2,106,122 | - |
| 319 | ABCL | AbCellera Biologics Inc. | 1.27B | 1.71% | 11,104,989 | 79.21M |
| 320 | BCAX | Bicara Therapeutics Inc. | 1.27B | -4.65% | 571,811 | - |
| 321 | WGS | GeneDx Holdings Corp. | 1.27B | 4.76% | 1,513,233 | 442.68M |
| 322 | AVBP | ArriVent BioPharma, Inc. | 1.26B | -2.98% | 367,352 | - |
| 323 | SVRA | Savara Inc. | 1.25B | -2.39% | 1,994,847 | - |
| 324 | ATEC | Alphatec Holdings, Inc. | 1.24B | 5.61% | 3,473,215 | 787.08M |
| 325 | NNNN | Anbio Biotechnology | 1.24B | 4.49% | 32,019 | 8.65M |
| 326 | WVE | Wave Life Sciences Ltd. | 1.23B | -5.47% | 6,559,232 | 71.80M |
| 327 | PNTG | The Pennant Group, Inc. | 1.23B | -0.59% | 168,049 | 1.02B |
| 328 | INSP | Inspire Medical Systems, Inc. | 1.21B | 4.44% | 1,601,407 | 915.25M |
| 329 | MPLT | MapLight Therapeutics, Inc. | 1.20B | -7.76% | 535,029 | - |
| 330 | COAG | Hemab Therapeutics Holdings, Inc. | 1.20B | -3.28% | 151,181 | - |
| 331 | MLTX | MoonLake Immunotherapeutics | 1.20B | -6.32% | 933,822 | - |
| 332 | SEPN | Septerna, Inc. | 1.19B | -2.41% | 316,921 | 72.26M |
| 333 | AVNS | Avanos Medical, Inc. | 1.16B | 0.12% | 849,559 | 715.90M |
| 334 | AORT | Artivion, Inc. | 1.15B | 4.35% | 1,019,730 | 458.69M |
| 335 | HROW | Harrow, Inc. | 1.15B | -0.99% | 746,940 | 268.68M |
| 336 | TDOC | Teladoc Health, Inc. | 1.15B | -0.16% | 3,398,338 | 2.51B |
| 337 | KMTS | Kestra Medical Technologies, Ltd. | 1.14B | -1.16% | 276,736 | 83.72M |
| 338 | IRMD | IRADIMED CORPORATION | 1.13B | 2.38% | 130,878 | 86.28M |
| 339 | DBVT | DBV Technologies S.A. | 1.13B | -4.58% | 174,370 | 5.74M |
| 340 | OLMA | Olema Pharmaceuticals, Inc. | 1.13B | -5.08% | 1,654,053 | - |
| 341 | AMN | AMN Healthcare Services, Inc. | 1.12B | 0.87% | 809,305 | 3.42B |
| 342 | AVLN | Avalyn Pharma Inc. | 1.11B | -10.76% | 430,258 | - |
| 343 | CNMD | CONMED Corporation | 1.10B | 3.16% | 392,724 | 1.37B |
| 344 | IART | Integra LifeSciences Holdings Corporation | 1.10B | 0.07% | 799,676 | 1.64B |
| 345 | COLL | Collegium Pharmaceutical, Inc. | 1.09B | -0.38% | 427,882 | 796.33M |
| 346 | NEO | NeoGenomics, Inc. | 1.09B | 1.58% | 1,216,413 | 745.97M |
| 347 | BLFS | BioLife Solutions, Inc. | 1.09B | 7.42% | 972,903 | 101.66M |
| 348 | JBIO | Jade Biosciences, Inc. | 1.09B | -5.78% | 374,596 | - |
| 349 | ZBIO | Zenas BioPharma, Inc. | 1.07B | -7.80% | 1,163,015 | 10.00M |
| 350 | IVA | Inventiva S.A. | 1.06B | -7.72% | 248,983 | 7.94M |
| 351 | CDNA | CareDx, Inc. | 1.06B | 3.10% | 894,951 | 412.82M |
| 352 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.05B | -1.69% | 2,290,635 | 204.73M |
| 353 | XERS | Xeris Biopharma Holdings, Inc. | 1.04B | -3.69% | 1,388,429 | 314.85M |
| 354 | AKTS | Aktis Oncology, Inc. | 1.03B | -4.81% | 155,830 | 8.28M |
| 355 | CRVS | Corvus Pharmaceuticals, Inc. | 1.03B | -0.81% | 2,796,131 | - |
| 356 | ALVO | Alvotech | 1.02B | -1.81% | 361,833 | 562.04M |
| 357 | BFLY | Butterfly Network, Inc. | 1.00B | 0.26% | 3,801,172 | 102.92M |
| 358 | USPH | U.S. Physical Therapy, Inc. | 989.83M | 3.55% | 402,647 | 787.69M |
| 359 | CRON | Cronos Group Inc. | 987.05M | -0.38% | 761,903 | 159.54M |
| 360 | INNV | InnovAge Holding Corp. | 984.09M | 1.83% | 244,374 | 949.17M |
| 361 | EYPT | EyePoint, Inc. | 980.94M | -5.26% | 732,049 | 7.61M |
| 362 | OMDA | Omada Health, Inc. | 979.12M | -0.54% | 1,042,894 | 283.30M |
| 363 | EVO | Evotec SE | 974.39M | 1.48% | 55,757 | 859.03M |
| 364 | LXRX | Lexicon Pharmaceuticals, Inc. | 950.38M | -4.04% | 2,226,679 | 69.64M |
| 365 | TNDM | Tandem Diabetes Care, Inc. | 927.20M | 5.54% | 4,718,585 | 1.03B |
| 366 | MNKD | MannKind Corporation | 923.76M | -3.24% | 5,152,104 | 360.78M |
| 367 | CGEM | Cullinan Therapeutics, Inc. | 913.88M | -5.47% | 1,941,017 | - |
| 368 | PHAT | Phathom Pharmaceuticals, Inc. | 904.71M | -4.04% | 1,313,388 | 204.89M |
| 369 | SDGR | Schrödinger, Inc. | 900.38M | 0.84% | 1,171,905 | 254.91M |
| 370 | INMD | InMode Ltd. | 893.36M | 1.44% | 967,516 | 374.64M |
| 371 | PHAR | Pharming Group N.V. | 892.68M | -2.32% | 18,809 | 369.49M |
| 372 | ETON | Eton Pharmaceuticals, Inc. | 889.98M | 7.37% | 413,671 | 86.93M |
| 373 | BVS | Bioventus Inc. | 887.97M | 0.47% | 425,556 | 576.30M |
| 374 | PCRX | Pacira BioSciences, Inc. | 882.97M | -0.88% | 316,850 | 734.86M |
| 375 | DRTS | Alpha Tau Medical Ltd. | 882.74M | -3.19% | 939,450 | - |
| 376 | TALK | Talkspace, Inc. | 871.07M | - | 1,098,500 | 238.37M |
| 377 | MGTX | MeiraGTx Holdings plc | 870.53M | - | 616,444 | 79.76M |
| 378 | NUTX | Nutex Health Inc. | 858.10M | -1.27% | 125,985 | 879.95M |
| 379 | JANX | Janux Therapeutics, Inc. | 855.61M | 1.01% | 725,948 | 13.73M |
| 380 | OPK | OPKO Health, Inc. | 853.25M | 2.73% | 2,581,417 | 581.12M |
| 381 | OMER | Omeros Corporation | 846.79M | -4.49% | 1,988,371 | 9.89M |
| 382 | GDRX | GoodRx Holdings, Inc. | 846.69M | 2.88% | 2,038,329 | 787.89M |
| 383 | SANA | Sana Biotechnology, Inc. | 846.01M | -0.98% | 2,950,347 | - |
| 384 | TBPH | Theravance Biopharma, Inc. | 838.25M | 0.25% | 371,935 | 109.78M |
| 385 | SPTX | Seaport Therapeutics, Inc. | 834.66M | -6.37% | 421,785 | - |
| 386 | AURA | Aura Biosciences, Inc. | 823.94M | -3.49% | 1,010,467 | - |
| 387 | ABUS | Arbutus Biopharma Corporation | 823.73M | -1.65% | 911,446 | 191.45M |
| 388 | ORIC | ORIC Pharmaceuticals, Inc. | 820.89M | -2.70% | 1,275,302 | - |
| 389 | ODTX | Odyssey Therapeutics, Inc. | 820.36M | -1.31% | 371,829 | 2.98M |
| 390 | XNCR | Xencor, Inc. | 820.01M | -1.43% | 854,126 | 97.36M |
| 391 | KURA | Kura Oncology, Inc. | 816.72M | -0.22% | 1,121,534 | 71.64M |
| 392 | ANNX | Annexon, Inc. | 812.66M | -4.80% | 3,279,860 | - |
| 393 | ESPR | Esperion Therapeutics, Inc. | 805.76M | 0.32% | 12,382,151 | 418.24M |
| 394 | SSII | SS Innovations International, Inc. | 799.76M | 3.63% | 26,875 | 48.47M |
| 395 | LBRX | LB Pharmaceuticals Inc | 795.49M | -6.47% | 229,196 | - |
| 396 | AVTX | Avalo Therapeutics, Inc. | 792.75M | -8.91% | 2,542,070 | 59.00K |
| 397 | GERN | Geron Corporation | 789.07M | -4.65% | 10,359,598 | 196.12M |
| 398 | EVMN | Evommune, Inc. | 788.44M | -4.49% | 523,296 | 10.00M |
| 399 | ABSI | Absci Corporation | 770.95M | -3.61% | 3,198,499 | 1.84M |
| 400 | VOR | Vor Biopharma Inc. | 765.64M | -3.42% | 827,927 | - |
| 401 | ANRO | Alto Neuroscience, Inc. | 764.15M | -5.13% | 689,896 | - |
| 402 | CTMX | CytomX Therapeutics, Inc. | 761.96M | -3.05% | 3,125,379 | 35.54M |
| 403 | AMPH | Amphastar Pharmaceuticals, Inc. | 758.40M | 1.96% | 866,027 | 720.53M |
| 404 | AZTA | Azenta, Inc. | 748.55M | 1.37% | 2,277,425 | 596.48M |
| 405 | SGP | SpyGlass Pharma, Inc. | 743.41M | -4.18% | 40,665 | - |
| 406 | QDEL | QuidelOrtho Corporation | 739.19M | 5.04% | 2,312,363 | 2.66B |
| 407 | DRUG | Bright Minds Biosciences Inc. | 728.19M | -3.19% | 357,140 | - |
| 408 | SPRY | ARS Pharmaceuticals, Inc. | 724.91M | -1.75% | 2,142,988 | 98.99M |
| 409 | CERT | Certara, Inc. | 709.37M | 1.79% | 3,055,166 | 419.75M |
| 410 | PSNL | Personalis, Inc. | 703.73M | 5.66% | 2,365,234 | 64.52M |
| 411 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 700.29M | 2.82% | 558,877 | - |
| 412 | HSTM | HealthStream, Inc. | 694.15M | 4.67% | 265,738 | 311.78M |
| 413 | AVR | Anteris Technologies Global Corp. | 685.11M | 4.56% | 1,070,189 | 1.85M |
| 414 | TENX | Tenax Therapeutics, Inc. | 684.17M | -3.01% | 828,481 | - |
| 415 | BIOA | BioAge Labs, Inc. | 681.90M | -13.14% | 451,903 | 10.32M |
| 416 | ALLO | Allogene Therapeutics, Inc. | 669.60M | -3.00% | 6,373,760 | 22.00K |
| 417 | DSGN | Design Therapeutics, Inc. | 668.29M | -25.54% | 7,646,240 | - |
| 418 | RLMD | Relmada Therapeutics, Inc. | 664.99M | -8.12% | 2,393,964 | - |
| 419 | SIBN | SI-BONE, Inc. | 654.60M | 4.24% | 722,970 | 206.22M |
| 420 | LMRI | Lumexa Imaging Holdings, Inc. | 650.47M | -3.70% | 1,326,930 | 1.03B |
| 421 | SLDB | Solid Biosciences Inc. | 640.91M | -5.92% | 1,028,455 | - |
| 422 | EIKN | Eikon Therapeutics, Inc. | 636.13M | -11.32% | 812,170 | - |
| 423 | CBLL | CeriBell, Inc. | 629.09M | 1.72% | 325,213 | 95.07M |
| 424 | TRAX | First Tracks Biotherapeutics, Inc. | 620.74M | 5.27% | 365,874 | - |
| 425 | CRMD | CorMedix Inc. | 620.55M | 4.77% | 2,004,544 | 400.05M |
| 426 | TLRY | Tilray Brands, Inc. | 617.89M | -2.63% | 3,481,144 | 858.28M |
| 427 | ZVRA | Zevra Therapeutics, Inc. | 616.57M | -5.27% | 2,285,218 | 122.29M |
| 428 | CBIO | Crescent Biopharma, Inc. | 616.40M | -7.11% | 416,081 | 11.88M |
| 429 | ACRS | Aclaris Therapeutics, Inc. | 614.52M | -2.65% | 1,827,407 | 8.37M |
| 430 | BWAY | BrainsWay Ltd. | 611.37M | -1.00% | 154,360 | 56.22M |
| 431 | GYRE | Gyre Therapeutics, Inc. | 588.44M | -1.68% | 75,610 | 117.05M |
| 432 | CSTL | Castle Biosciences, Inc. | 585.97M | 0.99% | 515,295 | 339.92M |
| 433 | CADL | Candel Therapeutics, Inc. | 578.83M | -9.92% | 4,225,378 | - |
| 434 | IRWD | Ironwood Pharmaceuticals, Inc. | 576.15M | -2.23% | 2,443,885 | 361.51M |
| 435 | STRO | Sutro Biopharma, Inc. | 571.26M | -11.52% | 408,534 | 99.61M |
| 436 | ARVN | Arvinas, Inc. | 566.50M | -3.30% | 975,286 | 89.40M |
| 437 | PHR | Phreesia, Inc. | 551.73M | 3.53% | 1,708,283 | 480.59M |
| 438 | NPCE | NeuroPace, Inc. | 545.16M | 4.10% | 154,620 | 99.53M |
| 439 | VALN | Valneva SE | 544.53M | 0.53% | 10,308 | 180.25M |
| 440 | ALT | Altimmune, Inc. | 544.53M | -1.75% | 3,462,113 | 36.00K |
| 441 | CABA | Cabaletta Bio, Inc. | 536.43M | -0.60% | 2,725,709 | - |
| 442 | MDXG | MiMedx Group, Inc. | 534.72M | 0.84% | 1,246,982 | 389.42M |
| 443 | TCMD | Tactile Systems Technology, Inc. | 533.46M | 4.00% | 285,140 | 343.52M |
| 444 | FBRX | Forte Biosciences, Inc. | 531.83M | -9.26% | 357,793 | - |
| 445 | RIGL | Rigel Pharmaceuticals, Inc. | 529.34M | -1.38% | 448,571 | 299.77M |
| 446 | TECX | Tectonic Therapeutic, Inc. | 522.68M | -0.68% | 377,852 | - |
| 447 | XOMA | XOMA Royalty Corporation | 522.21M | -0.26% | 96,099 | 48.56M |
| 448 | AGMB | AgomAb Therapeutics NV | 520.06M | 0.09% | 64,394 | - |
| 449 | AQST | Aquestive Therapeutics, Inc. | 518.74M | -0.84% | 2,688,452 | 50.27M |
| 450 | KYTX | Kyverna Therapeutics, Inc. | 516.93M | -10.01% | 1,427,387 | - |
| 451 | PRME | Prime Medicine, Inc. | 507.54M | -4.10% | 3,713,830 | 4.03M |
| 452 | MCTA | Charming Medical Limited | 504.26M | -0.85% | - | 5.42M |
| 453 | PRTA | Prothena Corporation plc | 502.07M | -1.74% | 650,972 | 57.94M |
| 454 | OFIX | Orthofix Medical Inc. | 490.72M | 1.08% | 294,713 | 825.37M |
| 455 | ACHV | Achieve Life Sciences, Inc. | 489.68M | -9.83% | 2,431,618 | - |
| 456 | CERS | Cerus Corporation | 486.90M | 3.85% | 1,981,022 | 216.56M |
| 457 | PROK | ProKidney Corp. | 486.16M | -3.01% | 968,053 | 889.00K |
| 458 | DNA | Ginkgo Bioworks Holdings, Inc. | 481.44M | -4.41% | 1,041,085 | 151.40M |
| 459 | CTNM | Contineum Therapeutics, Inc. | 480.79M | -6.27% | 152,406 | - |
| 460 | AUTL | Autolus Therapeutics plc | 479.06M | 10.43% | 5,951,326 | 92.62M |
| 461 | IMMX | Immix Biopharma, Inc. | 476.58M | -9.56% | 806,050 | - |
| 462 | CLYM | Climb Bio, Inc. | 471.95M | -8.52% | 634,650 | - |
| 463 | KIDS | OrthoPediatrics Corp. | 465.93M | 2.37% | 143,342 | 243.30M |
| 464 | SRTA | Strata Critical Medical, Inc. | 464.65M | 2.87% | 1,056,744 | 228.58M |
| 465 | ANL | Adlai Nortye Ltd. | 464.40M | -14.06% | 344,108 | 5.00M |
| 466 | UPB | Upstream Bio, Inc. | 463.11M | -6.38% | 511,346 | 3.32M |
| 467 | ANGO | AngioDynamics, Inc. | 461.42M | 2.79% | 245,162 | 313.73M |
| 468 | CTKB | Cytek Biosciences, Inc. | 458.46M | 4.26% | 1,428,191 | 204.17M |
| 469 | OCGN | Ocugen, Inc. | 453.62M | -3.60% | 6,563,853 | 4.47M |
| 470 | KMDA | Kamada Ltd. | 451.71M | 1.56% | 80,193 | 181.68M |
| 471 | STTK | Shattuck Labs, Inc. | 451.22M | -4.63% | 609,005 | 1.00M |
| 472 | FLGT | Fulgent Genetics, Inc. | 450.15M | 0.96% | 499,338 | 320.35M |
| 473 | ARTV | Artiva Biotherapeutics, Inc. | 447.98M | -5.73% | 517,617 | 251.00K |
| 474 | NGNE | Neurogene Inc. | 442.14M | -6.17% | 176,814 | 925.00K |
| 475 | VTVT | vTv Therapeutics Inc. | 440.41M | -0.59% | 45,083 | 36.84M |
| 476 | EVH | Evolent Health, Inc. | 438.68M | -1.52% | 1,968,709 | 1.89B |
| 477 | FDMT | 4D Molecular Therapeutics, Inc. | 437.29M | -8.58% | 1,033,498 | 88.24M |
| 478 | PRLD | Prelude Therapeutics Incorporated | 436.51M | -3.13% | 463,521 | 16.72M |
| 479 | ASMB | Assembly Biosciences, Inc. | 435.78M | -4.29% | 204,164 | 71.10M |
| 480 | WEAV | Weave Communications, Inc. | 432.84M | 3.03% | 929,633 | 248.72M |
| 481 | EOLS | Evolus, Inc. | 432.67M | 1.08% | 985,707 | 301.79M |
| 482 | PRTC | PureTech Health plc | 431.03M | -3.79% | 5,457 | 4.66M |
| 483 | CATX | Perspective Therapeutics, Inc. | 428.81M | -2.34% | 1,111,644 | 618.00K |
| 484 | EPRX | Eupraxia Pharmaceuticals Inc. | 426.36M | -3.32% | 165,133 | - |
| 485 | CCRN | Cross Country Healthcare, Inc. | 423.56M | -0.23% | 1,902,991 | 1.00B |
| 486 | NRC | NRC Health | 422.34M | 0.64% | 92,805 | 138.64M |
| 487 | EBS | Emergent BioSolutions Inc. | 419.48M | 2.39% | 863,643 | 676.80M |
| 488 | BBNX | Beta Bionics, Inc. | 418.88M | -0.63% | 964,689 | 110.24M |
| 489 | OVID | Ovid Therapeutics Inc. | 417.02M | -8.37% | 1,370,283 | 7.12M |
| 490 | REPL | Replimune Group, Inc. | 413.69M | -4.02% | 5,118,010 | - |
| 491 | SGMT | Sagimet Biosciences Inc. | 411.27M | -3.48% | 1,130,540 | - |
| 492 | IPSC | Century Therapeutics, Inc. | 411.21M | -2.56% | 1,417,625 | 109.16M |
| 493 | MOBI | Mobia Medical, Inc. | 409.27M | 3.95% | 56,701 | 32.04M |
| 494 | VREX | Varex Imaging Corporation | 408.82M | 0.41% | 621,258 | 857.50M |
| 495 | FULC | Fulcrum Therapeutics, Inc. | 405.80M | -8.97% | 572,914 | 80.00M |
| 496 | ADCT | ADC Therapeutics SA | 403.20M | -2.46% | 1,434,554 | 79.18M |
| 497 | TOI | The Oncology Institute, Inc. | 399.93M | 0.50% | 1,062,750 | 545.76M |
| 498 | CGC | Canopy Growth Corporation | 392.95M | -5.55% | 11,356,509 | 203.04M |
| 499 | ENTA | Enanta Pharmaceuticals, Inc. | 391.10M | 0.30% | 259,330 | 69.21M |
| 500 | ZURA | Zura Bio Limited | 390.91M | -12.71% | 678,073 | - |